Scarica l'app Stockscreener
1.5235
7.64%
0.0835
Precedente Chiudi:
$1.44
Aprire:
$1.44
Volume 24 ore:
99,705
Relative Volume:
0.20
Capitalizzazione di mercato:
$50.43M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-17.27
EPS:
-0.0882
Flusso di cassa netto:
-
1 W Prestazione:
+20.16%
1M Prestazione:
-4.32%
6M Prestazione:
+121.75%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$1.41
$1.59
Intervallo di 1 settimana:
$1.2496
$1.66
Portata 52W:
$0.51
$19.51
Jupiter Neurosciences Inc Stock (JUNS) Company Profile
Nome
Jupiter Neurosciences Inc
Settore
Industria
Telefono
(561) 406-6154
Indirizzo
1001 NORTH US HWY 1, JUPITER
Confronta JUNS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
JUNS
Jupiter Neurosciences Inc
|
1.5235 | 41.05M | 0 | 0 | 0 | -0.0882 |
|
VRTX
Vertex Pharmaceuticals Inc
|
384.53 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
579.09 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.97 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
696.92 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.95 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Jupiter Neurosciences Inc Borsa (JUNS) Ultime notizie
Jupiter Neurosciences (JUNS) Surges 17% on High-Profile Partnership with NBA Legend Chris Webber – Is This the Catalyst for a Longevity Market Breakout? - AInvest
Combining price and volume data for Jupiter Neurosciences Inc.Portfolio Performance Summary & AI Forecasted Entry/Exit Points - Newser
Multi asset correlation models including Jupiter Neurosciences Inc.Market Growth Review & Capital Protection Trading Alerts - Newser
Analyzing recovery setups for Jupiter Neurosciences Inc. investorsJuly 2025 PreEarnings & Growth Focused Entry Point Reports - Newser
Real time scanner hits for Jupiter Neurosciences Inc. explainedJuly 2025 Momentum & Risk Controlled Swing Trade Alerts - Newser
Will Jupiter Neurosciences Inc. benefit from macro trendsRate Hike & Low Risk Investment Opportunities - Newser
Intrinsic Value of Jupiter Neurosciences Inc. Stock: Is It Undervalued or OvervaluedEarnings Summary Report & Breakout Confirmation Alerts - Newser
Longevity In A Capsule: Jupiter Neurosciences Launches First Three Supplements Under Nugevia™ Brand - NewMediaWire
Jupiter Neurosciences launches Nugevia MND to support cognitive function and brain health - Nutritional Outlook
Jupiter Neurosciences Inc. recovery potential after sell offJuly 2025 Movers & Expert Approved Momentum Ideas - Newser
Jupiter Neurosciences names NBA Legend Chris Webber as second Nugevia brand ambassador - Mass Market Retailers
Jupiter Neurosciences Launches Nugevia™ Longevity Supplement Line to Accelerate Revenue While Developing CNS Treatments - citybuzz -
Longevity In A Capsule: Jupiter Neurosciences Launches First Three Supplements Under Nugevia(TM) Brand - FinancialContent
Jupiter Neurosciences Names NBA Legend Chris Webber as Second Nugevia™ Brand Ambassador - GlobeNewswire
5-Time NBA All-Star Chris Webber Partners with Jupiter Neurosciences for $8T Longevity Market Push - Stock Titan
When is the best time to buy Jupiter Neurosciences Inc. stockWeekly Loss Report & High Return Stock Watch Alerts - Newser
Jupiter Neurosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Chart based analysis of Jupiter Neurosciences Inc. trendsPortfolio Value Report & Expert Verified Stock Movement Alerts - Newser
Jupiter Neurosciences Inc. stock prediction for this weekQuarterly Portfolio Report & Daily Volume Surge Signals - Newser
Is Jupiter Neurosciences Inc. Starting a New UptrendQuarterly Portfolio Summary & AI Driven Stock Price Forecasts - 선데이타임즈
Will Jupiter Neurosciences Inc. Bounce From 52 Week Low2025 Price Momentum & Fast Moving Stock Watchlists - newsimpact.co.kr
Recovery Signals Appearing in Jupiter Neurosciences Inc. ChartsEntry Point & Capital Efficiency Focused Ideas - sundaytimes.kr
Visual trend scoring systems applied to Jupiter Neurosciences Inc.2025 Technical Overview & Stock Timing and Entry Methods - Newser
Why Jupiter Neurosciences Inc. stock attracts strong analyst attentionTrade Performance Summary & AI Enhanced Market Trend Forecasts - thegnnews.com
Is Jupiter Neurosciences Inc. stock poised for growthJuly 2025 Update & Consistent Return Strategy Ideas - Newser
Is Jupiter Neurosciences Inc. a Top Dividend Stock to Watch in 2025Trend Reversal & Daily Stock Momentum Reports - Newser
Is a relief rally coming for Jupiter Neurosciences Inc. holdersJuly 2025 Spike Watch & Growth Focused Investment Plans - Newser
Applying chart zones and confluence areas to NLY.PRF2025 Breakouts & Breakdowns & Verified Momentum Stock Alerts - Newser
What to do if you’re stuck in URGNJuly 2025 Review & Low Risk High Win Rate Stock Picks - Newser
Real time breakdown of Jupiter Neurosciences Inc. stock performanceCPI Data & Free Community Supported Trade Ideas - Newser
Can Jupiter Neurosciences Inc. disrupt its industryWeekly Stock Recap & Weekly Top Gainers Alerts - newsyoung.net
Will earnings trigger a reversal in FVNNUDollar Strength & High Return Stock Watch Alerts - Newser
SBXD stock prediction for this weekWeekly Trade Recap & Fast Entry Momentum Trade Alerts - Newser
Is now a turning point for Jupiter Neurosciences Inc.Quarterly Market Review & Fast Gaining Stock Reports - Newser
Jupiter Neurosciences Reports Delay in Q2 Financial Filing - AInvest
Jupiter Neurosciences Inc Azioni (JUNS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Jupiter Neurosciences Inc Azioni (JUNS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Silva Alison D. | Pres + Chief Business Officer |
Jul 01 '25 |
Buy |
1.03 |
750 |
772 |
112,777 |
| ROSEN CHRISTER | CEO and Chairman |
Jul 01 '25 |
Buy |
1.02 |
3,600 |
3,667 |
11,078,892 |
| Silva Alison D. | Pres + Chief Business Officer |
Jun 02 '25 |
Option Exercise |
0.00 |
110,227 |
0 |
110,227 |
| Silva Alison D. | Pres + Chief Business Officer |
Jun 30 '25 |
Buy |
1.03 |
950 |
978 |
112,027 |
| Silva Alison D. | Pres + Chief Business Officer |
Jun 27 '25 |
Buy |
1.03 |
850 |
877 |
111,077 |
| ROSEN CHRISTER | CEO and Chairman |
Jun 02 '25 |
Option Exercise |
0.00 |
973,466 |
0 |
11,067,476 |
| ROSEN CHRISTER | CEO and Chairman |
Jun 30 '25 |
Buy |
1.02 |
7,650 |
7,810 |
11,075,292 |
| ROSEN CHRISTER | CEO and Chairman |
Jun 27 '25 |
Buy |
1.06 |
166 |
176 |
11,067,642 |
0.60%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):